Anticoagulation
|
Anticoagulation |
|
Factor XA Inhibition Factor IX Inhibition Warfarin |
| Pathophysiology |
Heparin-Induced Thrombocytopenia
-Heparin as a Cause of Thrombosis and "The HIT Syndromes" by Dr. Amjad AlMahameed
Hypercoaguable States
-What Every Clinician Needs to Know by Dr. Amjad AlMahameed
| Factor XA Inhibition |
New Approaches to Chronic Anticoagulation: Factor XA Inhibition
-Meeting the Unmet Needs in Chronic Anticoagulation by Dr. C. Michael Gibson (ACC 2007)
XA Inhibitors
-Are They All the Same? by Dr. Alexander G. G. Turpie
| Factor IX Inhibition |
Aptamer Technology Overview:
-Factor IXa Inhibition Aptamer Technology Overview and First Results with RB006/RB007 by Dr. Mauricio G. Cohen (TCT 2009)
| Warfarin |
GRACE Registry: Global Registry of Acute Coronary Events
-Combining Warfarin and Antiplatelet Therapy After Coronary Stenting: Is It Safe and Effective to Use Just One Antiplatelet Agent? by Dr. Michael C. Nguyen
Who Are We? Slide Downloading Policy Financial Disclosure We Do Not Promote Off Label Product Use Copyright Source of Slides Editorial Policy Links Policy Privacy Policy Access CME Programs
© 1999-2009 by Clinical Trial Results .org. None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results. All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster